Orange Book product · Generic (ANDA)
ETHACRYNIC ACID
ETHACRYNIC ACID
At a glance
Feb 19, 2020
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 19, 2020
6 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
ETHACRYNIC ACID
Strength
25MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 212417
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ETHACRYNIC ACID
- —EDECRINBrand (NDA)
NDA 016092 · BAUSCH
- 2020ETHACRYNIC ACIDGeneric (ANDA)
ANDA 213240 · CHARTWELL RX
- 2019ETHACRYNIC ACIDGeneric (ANDA)
ANDA 211719 · LUPIN
- 2019ETHACRYNIC ACIDGeneric (ANDA)
ANDA 211232 · SCIEGEN PHARMS
- 2019ETHACRYNIC ACIDGeneric (ANDA)
ANDA 211809 · AGNITIO
- 2018ETHACRYNIC ACIDGeneric (ANDA)
ANDA 205709 · ALVOGEN
- 2018ETHACRYNIC ACIDGeneric (ANDA)
ANDA 208805 · AMNEAL PHARMS CO
- 2017ETHACRYNIC ACIDGeneric (ANDA)
ANDA 208501 · PH HEALTH
- 2017ETHACRYNIC ACIDGeneric (ANDA)
ANDA 207262 · HIKMA
- 2016ETHACRYNIC ACIDGeneric (ANDA)
ANDA 205609 · ADAPTIS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
